Could there soon be a vaccine for the common cold?

Jump to contentAllNewsSportCultureLifestyleAn early clinical trial of a new vaccine candidate, APL-10456, has shown encouraging signs of protecting against the common cold. Developed by Imperial College London and Apollo Therapeutics, the jab induced immune responses against all three major species of rhinovirus in 144 healthy volunteers. Vaccinating against rhinoviruses has long been considered difficult due to the existence of around 180 circulating strains worldwide. Scientists hope the vaccine will help protect vulnerable patients with asthma and chronic obstructive pulmonary disease (COPD), for whom colds can trigger severe flare-ups. The study is now moving into its second phase, with further results expected at the end of the year and a COPD-specific trial planned for 2027. In fullEarly trials for vaccine for common cold are ‘encouraging’, scientists sayMore bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Raccontata daindependent.co.uk